Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,079 | -112,673 | -133,204 | -151,078 | -88,444 |
| Depreciation Amortization | -1,091 | -3,204 | 1,733 | 5,974 | 1,165 |
| Accounts payable and accrued liabilities | 1,523 | -4,148 | 4,025 | -3,195 | 2,807 |
| Other Working Capital | -17,893 | 5,876 | 6,178 | -1,620 | 6,460 |
| Other Operating Activity | 38,105 | 35,567 | 30,342 | 31,995 | 40,100 |
| Operating Cash Flow | $-65,435 | $-78,582 | $-90,926 | $-117,924 | $-37,912 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -679 | -577 | -4,260 | -9,568 |
| Purchase Of Investment | -89,232 | -212,957 | -367,124 | -177,734 | -229,328 |
| Sale Of Investment | 174,671 | 280,004 | 335,479 | 245,718 | 78,661 |
| Investing Cash Flow | $85,435 | $66,368 | $-32,222 | $63,724 | $-160,235 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 151,275 |
| Debt Repayment | N/A | N/A | N/A | -5 | -32 |
| Common Stock Issued | 245 | 567 | 851 | 4,465 | 264,370 |
| Financing Cash Flow | $245 | $567 | $851 | $4,460 | $415,613 |
| Beginning Cash Position | 66,352 | 77,999 | 200,296 | 250,036 | 32,570 |
| End Cash Position | 86,597 | 66,352 | 77,999 | 200,296 | 250,036 |
| Net Cash Flow | $20,245 | $-11,647 | $-122,297 | $-49,740 | $217,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,435 | -78,582 | -90,926 | -117,924 | -37,912 |
| Capital Expenditure | -4 | -679 | -577 | -4,260 | -9,568 |
| Free Cash Flow | -65,439 | -79,261 | -91,503 | -122,184 | -47,480 |